INTRODUCTION
Testicular tumours are respectively rare neoplasm; they make up for approximately 2% of all malignant tumours in men and account for up to 10% of all malignant diseases occurring within the male genitourinary system. Approximately 95% of all testicular neoplasms are of germ cell origin. WHO classification divides germ cell tumours into two categories. About 40% of the tumours are composed entirely of a single histologic pattern such as seminoma, spermatocytic seminoma, embryonal carcinoma, yolk sac tumour, choriocarcinoma, and teratoma (mature and immature). The remaining 60% contain a mixture of two or more histologic patterns, known as mixed germ cell tumour. 1 
CASE REPORT
A 18 year old male patient came with a complaint of pain abdomen since 3 months & swelling in the left side of scrotum since 1½ months. Swelling gradually increased in size, attained the present size and associated with heaviness in the scrotum. There is history of loss of weight, loss of appetite & back pain. On examination left testis is enlarged measuring 8 x 5 cm, hard in consistency, non-tender with nodular surface. Right testis is normal. On examining the abdomen a 6 x 4 cm firm non-tender lump is noted with nodular surface occupying left hypochondriac & lumbar regions. In the left supraclavicular fossa 3 x 2 cm hard non-tender matted lymph nodes are present (Figure 1 ). Other blood investigations are with in normal limits. Patient is nonreactive to HIV. 
DISCUSSION
Approximately 95% of all testicular neoplasms are of germ cell origin. For unclear reasons, there has been a worldwide increase in the incidence of these tumours. 1 More importantly, Testicular tumours are the most common malignant diseases, developing in men between 20 and 40 years of age and are the third leading cause of death among men of this age group. 2 The most well documented risk factor for the development of germ cell tumours is cryptorchidism. Testicular dysgenesis, a history of contralateral tumour, and genetic factors also play a role. Recently HIV infection is thought to be a risk factor. 3 The most consistent chromosomal abnormality is an isochromosome of the short arm of chromosome 12, I (12p), which is present in 56% of seminomas and in83% of nonseminomatous tumours. 4 Approximately 1.35% of patients also have a first degree relative with germ cell tumour of the testis. The relative risk for first degree relatives is 3-10 fold. 5 Patients with germ cell tumour in one testicle have a 500-1000 fold greater chance of developing a contralateral testicular carcinoma.
The average age of presentation for patients with mixed germ cell tumours is 30 years. The most frequent combination is that of embryonal carcinoma, seminoma, yolk sac tumour, teratoma, and choriocarcinoma. Despite the presence of seminoma these tumours are managed as Non Seminomatous Germ Cell Tumors (NSGCTs). Unfortunately many of these patients present late usually with some complications which are difficult to treat and carry bad prognosis. Still if they complete the chemotherapy they have a reasonable survival period depending on the associated complications.
Germ cell tumours except spermatocytic seminoma 6 spreads lymphogenously to retroperitoneal and mediastinal nodes and to the left supraclavicular node (Virchow node). Haematogenous metastases usually go to lungs, liver, brain, or bones. The likelihood of a patient presenting with metastatic disease is approximately 20% for seminomas and higher 30 to 60% for nonseminomatous tumours. 3 The metastasis usually reflects the histology of the basic primary tumour. However, different histologic cell types are found more often in metastases than in primary tumours. This may be due to maturation of one germ-cell type into another cell type. In general, 90 to 100% of patients with localized tumours can be cured and up to 70% with metastatic disease can be cured. The therapy and prognosis of testicular tumours can depend largely on clinical stage and on histological type. Another important factor significantly contributing to the definite cure is completion of the treatment and regular follow-up of the patient. β-human chorionic gonadotropin and/or alphafetoprotein serum levels are elevated in about 75% of patients with NSGCT, the levels drop with treatment, and usually, rise with recurrence but not always. 7 A 2 year disease-free interval indicates cure in about 90% of patients. 8 Seminomas are monomorphic and necrosis is uncommon. They tend to remain localized to the testis for a longer period of time and thus present at an earlier clinical stage. They are extremely radiosensitive and have cure rates greater than 95%. Nonseminomatous germ cell tumours, including mature and immature teratomas, have a variegated appearance and often display haemorrhage and necrosis. These tumours are biologically more aggressive and radio resistant. These tumours still carry a relatively high rate of remission with aggressive chemotherapy, including 60-75% remission with clinical stage III disease.
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